NASDAQ : EVGN
Evogene Ltd. — Financial statements
Healthcare · Biotechnology · Israel
Last price 0.3746 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 5.84M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Evogene Ltd. (EVGN) reported revenue of 1.66M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.66M | 3.85M | 5.58M | 2.98M | 1.68M | 930.00K |
| Cost of Revenue | 2.78M | 4.09M | 2.38M | 1.49M | 909.00K | 767.00K |
| Gross Profit | -1.12M | -241.00K | 3.20M | 1.49M | 766.00K | 163.00K |
| Selling, General & Admin | 5.69M | 5.76M | 8.98M | 7.53M | 10.41M | 9.99M |
| Research & Development | 7.43M | 7.99M | 12.51M | 16.20M | 20.79M | 21.12M |
| Other Operating Expenses | -18.00K | -209.00K | -3.50M | |||
| Operating Expenses | 13.10M | 13.55M | 21.49M | 23.72M | 27.71M | 31.12M |
| Operating Income | -14.22M | -13.79M | -18.29M | -22.23M | -26.94M | -30.95M |
| Interest Expense | -157.00K | -63.00K | -114.00K | -165.00K | -315.00K | |
| Interest & Investment Income | 633.00K | 356.00K | 815.00K | 978.00K | 182.00K | 291.00K |
| Earnings From Equity Investments | -16.00K | -39.00K | -39.00K | |||
| Currency Exchange Gain (Loss) | -292.00K | -292.00K | -78.00K | -221.00K | -1.74M | 1.06M |
| Other Non Operating Income (Expenses) | -2.33M | 668.00K | 3.36M | -403.00K | -368.00K | -458.00K |
| EBT Excluding Unusual Items | -16.23M | -13.25M | -14.29M | -21.99M | -29.03M | -30.37M |
| Merger & Restructuring Charges | -514.00K | |||||
| Gain (Loss) on Sale of Investments | 45.00K | -721.00K | -62.00K | |||
| Asset Writedown | -362.00K | -246.00K | ||||
| Pretax Income | -16.58M | -13.50M | -14.81M | -21.95M | -29.75M | -30.43M |
| Income Tax Expense | 1.00K | 9.00K | 19.00K | 90.00K | 13.00K | |
| Earnings From Continuing Operations | -16.58M | -13.50M | -14.82M | -21.96M | -29.84M | -30.45M |
| Earnings From Discontinued Operations | 8.76M | 5.67M | -3.24M | -3.99M | ||
| Net Income to Company | -7.82M | -7.83M | -18.05M | -25.95M | -29.84M | -30.45M |
| Minority Interest in Earnings | -1.25M | -658.00K | 1.57M | 2.08M | 3.21M | 2.65M |
| Net Income | -9.07M | -8.48M | -16.48M | -23.88M | -26.64M | -27.79M |
| Net Income to Common | -9.07M | -8.48M | -16.48M | -23.88M | -26.64M | -27.79M |
| Shares Outstanding (Basic) | 10.07M | 7.87M | 5.70M | 4.59M | 4.14M | 4.04M |
| Shares Outstanding (Diluted) | 10.07M | 7.87M | 5.70M | 4.59M | 4.14M | 4.04M |
| EPS (Basic) | -0.90 | -1.08 | -2.89 | -5.20 | -6.43 | -6.87 |
| EPS (Diluted) | -0.90 | -1.08 | -2.89 | -5.20 | -6.43 | -6.87 |
| Free Cash Flow | -10.97M | -13.64M | -20.33M | -22.15M | -24.85M | -25.56M |
| Free Cash Flow Per Share | -1.09 | -1.73 | -3.57 | -4.83 | -6.00 | -6.32 |
| Gross Margin | -67.59% | -6.25% | 57.33% | 50.03% | 45.73% | 17.53% |
| Operating Margin | -858.18% | -357.85% | -327.95% | -745.51% | -1,608.42% | -3,328.28% |
| Profit Margin | -547.56% | -220.22% | -295.59% | -800.77% | -1,590.33% | -2,988.49% |
| Free Cash Flow Margin | -662.10% | -353.93% | -364.46% | -742.92% | -1,483.52% | -2,748.71% |
| EBITDA | -13.87M | -13.26M | -17.71M | -20.93M | -24.36M | -28.72M |
| D&A For EBITDA | 351.00K | 524.00K | 584.00K | 1.30M | 2.58M | 2.23M |
| EBIT | -14.22M | -13.79M | -18.29M | -22.23M | -26.94M | -30.95M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.32M | 12.96M | 15.30M | 20.77M | 28.98M | 32.33M |
| Short-Term Investments | 10.29M | 3.00M | ||||
| Trading Asset Securities | 6.38M | 18.54M | ||||
| Cash & Short-Term Investments | 9.32M | 12.96M | 15.30M | 31.06M | 35.35M | 53.87M |
| Accounts Receivable | 384.00K | 317.00K | 1.09M | 357.00K | 348.00K | 281.00K |
| Other Receivables | 128.00K | 355.00K | 342.00K | 314.00K | 353.00K | 885.00K |
| Receivables | 512.00K | 672.00K | 1.43M | 671.00K | 701.00K | 1.17M |
| Inventory | 93.00K | 210.00K | 1.82M | 76.00K | 566.00K | 92.00K |
| Prepaid Expenses | 898.00K | 1.21M | 362.00K | 1.04M | 1.10M | 1.69M |
| Restricted Cash | 35.00K | 32.00K | 10.00K | 32.00K | 77.00K | |
| Other Current Assets | 551.00K | 2.66M | 1.62M | |||
| Total Current Assets | 10.85M | 15.63M | 21.59M | 34.47M | 37.75M | 56.89M |
| Property, Plant & Equipment | 2.06M | 2.64M | 4.25M | 3.44M | 4.07M | 4.18M |
| Long-Term Investments | 43.00K | 82.00K | ||||
| Other Intangible Assets | 12.20M | 13.17M | 14.14M | 15.21M | ||
| Long-Term Deferred Tax Assets | 94.00K | |||||
| Long-Term Deferred Charges | 1.17M | 1.74M | ||||
| Other Long-Term Assets | 531.00K | 571.00K | 12.00K | 28.00K | 74.00K | 25.00K |
| Total Assets | 13.44M | 20.05M | 39.86M | 51.10M | 56.13M | 76.30M |
| Accounts Payable | 394.00K | 639.00K | 1.23M | 1.78M | 1.04M | 1.46M |
| Accrued Expenses | 911.00K | 1.08M | 2.19M | 3.09M | 2.37M | 3.15M |
| Current Portion of Leases | 668.00K | 716.00K | 589.00K | 853.00K | 884.00K | 974.00K |
| Current Unearned Revenue | 110.00K | 73.00K | 683.00K | 750.00K | 101.00K | 264.00K |
| Other Current Liabilities | 961.00K | 940.00K | 14.00M | 462.00K | 1.24M | 1.03M |
| Total Current Liabilities | 3.04M | 3.44M | 18.70M | 6.94M | 5.62M | 6.88M |
| Long-Term Leases | 1.43M | 1.48M | 1.91M | 285.00K | 932.00K | 1.70M |
| Long-Term Unearned Revenue | 3.19M | 3.15M | 4.42M | 4.82M | 4.67M | 4.31M |
| Other Long-Term Liabilities | 10.37M | 10.11M | ||||
| Total Liabilities | 7.67M | 8.07M | 25.03M | 22.42M | 21.34M | 12.88M |
| Common Stock | 804.00K | 488.00K | 363.00K | 286.00K | 235.00K | 234.00K |
| Additional Paid-In Capital | 286.10M | 281.99M | 272.26M | 269.35M | 261.40M | 260.49M |
| Retained Earnings | -290.19M | -282.56M | -274.07M | -257.59M | -233.71M | -207.07M |
| Total Common Equity | -3.29M | -82.00K | -1.45M | 12.05M | 27.93M | 53.65M |
| Minority Interest | 9.06M | 12.06M | 16.29M | 16.63M | 6.86M | 9.77M |
| Shareholders' Equity | 5.77M | 11.97M | 14.84M | 28.68M | 34.79M | 63.42M |
| Total Liabilities & Equity | 13.44M | 20.05M | 39.86M | 51.10M | 56.13M | 76.30M |
| Total Debt | 2.10M | 2.20M | 2.50M | 1.14M | 1.82M | 2.67M |
| Net Cash (Debt) | 7.21M | 10.76M | 12.80M | 29.93M | 33.54M | 51.20M |
| Net Cash Per Share | 0.72 | 1.37 | 2.25 | 6.52 | 8.10 | 12.66 |
| Filing Date Shares Outstanding | 13.54M | 9.89M | 6.67M | 5.06M | 4.16M | 4.12M |
| Total Common Shares Outstanding | 13.54M | 8.72M | 6.51M | 5.06M | 4.13M | 4.12M |
| Working Capital | 7.81M | 12.19M | 2.89M | 27.52M | 32.13M | 50.01M |
| Book Value Per Share | -0.24 | -0.01 | -0.22 | 2.38 | 6.77 | 13.03 |
| Tangible Book Value | -3.29M | -82.00K | -13.65M | -1.12M | 13.79M | 38.45M |
| Tangible Book Value Per Share | -0.24 | -0.01 | -2.09 | -0.22 | 3.34 | 9.34 |
| Machinery | 6.45M | 8.12M | 7.54M | 6.95M | 6.12M | |
| Leasehold Improvements | 12.92M | 13.10M | 14.03M | 13.87M | 13.51M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -9.07M | -8.48M | -16.48M | -23.88M | -26.64M | -27.79M |
| Depreciation & Amortization | 971.00K | 1.14M | 1.38M | 1.30M | 2.58M | 2.23M |
| Other Amortization | 2.38M | 1.32M | 471.00K | |||
| Loss (Gain) From Sale of Assets | -29.00K | -209.00K | 525.00K | -26.00K | 121.00K | |
| Asset Writedown & Restructuring Costs | 362.00K | 246.00K | ||||
| Loss (Gain) on Equity Investments | 15.00K | 39.00K | 39.00K | |||
| Stock-Based Compensation | 302.00K | 654.00K | 1.24M | 1.11M | 1.19M | 2.61M |
| Other Operating Activities | -5.73M | -4.85M | -2.08M | 2.23M | -35.00K | -3.54M |
| Change in Accounts Receivable | 661.00K | 665.00K | -627.00K | -7.00K | -67.00K | -59.00K |
| Change in Inventory | -301.00K | -1.02M | -1.28M | 489.00K | -474.00K | -92.00K |
| Change in Accounts Payable | -220.00K | -259.00K | -630.00K | 757.00K | -469.00K | 625.00K |
| Change in Unearned Revenue | -13.00K | -361.00K | -559.00K | -288.00K | -153.00K | 128.00K |
| Change in Other Net Operating Assets | -941.00K | -279.00K | 480.00K | -1.23M | 486.00K | 1.05M |
| Operating Cash Flow | -10.95M | -13.50M | -19.70M | -21.58M | -23.68M | -24.72M |
| Capital Expenditures | -24.00K | -135.00K | -626.00K | -577.00K | -1.17M | -847.00K |
| Sale of Property, Plant & Equipment | 190.00K | 78.00K | 10.00K | 26.00K | ||
| Investment in Securities | 1.00M | -1.00K | 10.19M | -3.78M | 14.45M | -19.72M |
| Other Investing Activities | 20.14M | 17.80M | 48.00K | -208.00K | ||
| Investing Cash Flow | 21.31M | 17.74M | 9.62M | -4.54M | 13.27M | -20.57M |
| Long-Term Debt Repaid | -526.00K | -886.00K | -675.00K | -803.00K | -580.00K | |
| Lease Payments | -511.00K | -526.00K | -886.00K | -675.00K | -803.00K | -580.00K |
| Net Debt Issued (Repaid) | -511.00K | -526.00K | -886.00K | -675.00K | -803.00K | -580.00K |
| Issuance of Common Stock | 805.00K | 4.28M | 5.62M | 8.45M | 28.00K | 30.07M |
| Other Financing Activities | -9.73M | -10.36M | -81.00K | 10.38M | 10.12M | 790.00K |
| Financing Cash Flow | -9.44M | -6.60M | 4.66M | 18.15M | 9.34M | 30.28M |
| Foreign Exchange Rate Adjustments | -7.00K | 21.00K | -49.00K | -245.00K | -2.28M | 1.10M |
| Net Cash Flow | 987.00K | -2.35M | -5.47M | -8.21M | -3.35M | -13.90M |
| Free Cash Flow | -10.97M | -13.64M | -20.33M | -22.15M | -24.85M | -25.56M |
| Free Cash Flow Margin | -662.10% | -353.93% | -364.46% | -742.92% | -1,483.52% | -2,748.71% |
| Free Cash Flow Per Share | -1.09 | -1.73 | -3.57 | -4.83 | -6.00 | -6.32 |
| Levered Free Cash Flow | -1.98M | -17.49M | 131.38K | -11.79M | -14.89M | -17.97M |
| Unlevered Free Cash Flow | -1.98M | -17.40M | 170.75K | -11.72M | -14.78M | -17.77M |
| Free Cash Flow After Leases | -11.48M | -14.16M | -21.21M | -22.83M | -25.65M | -26.14M |
| Cash Interest Paid | 126.00K | 193.00K | 67.00K | 121.00K | 165.00K | 315.00K |
| Cash Income Tax Paid | 5.00K | 11.00K | 11.00K | 31.00K | 40.00K | 13.00K |
| Change in Working Capital | -814.00K | -1.25M | -2.61M | -278.00K | -771.00K | 1.66M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 5.48M | 8.22M | 13.00M | 42.08M | 26.20M | 71.14M |
| Enterprise Value | 7.23M | 10.99M | 10.26M | 22.35M | -2.47M | 20.49M |
| Last Close Price | 0.37 | 1.10 | 1.87 | 8.40 | 7.00 | 16.40 |
| PS Ratio | 3.43 | 2.13 | 2.33 | 14.11 | 15.64 | 76.49 |
| PB Ratio | 0.99 | 0.69 | 0.88 | 1.47 | 0.75 | 1.12 |
| P/TBV Ratio | 1.90 | 1.85 | ||||
| EV/Sales Ratio | 4.49 | 2.85 | 1.84 | 7.49 | 22.04 | |
| Debt / Equity Ratio | 0.36 | 0.18 | 0.17 | 0.04 | 0.05 | 0.04 |
| Net Debt / Equity Ratio | -1.25 | -0.90 | -0.86 | -1.04 | -0.96 | -0.81 |
| Net Debt / EBITDA Ratio | 0.52 | 0.81 | 0.72 | 1.43 | 1.38 | 1.78 |
| Net Debt / FCF Ratio | 0.66 | 0.79 | 0.63 | 1.35 | 1.35 | 2.00 |
| Asset Turnover | 0.07 | 0.13 | 0.12 | 0.06 | 0.03 | 0.01 |
| Inventory Turnover | 2.71 | 4.04 | 2.51 | 4.64 | 2.76 | |
| Quick Ratio | 3.23 | 3.96 | 0.90 | 4.57 | 6.41 | 8.00 |
| Current Ratio | 3.57 | 4.54 | 1.16 | 4.96 | 6.71 | 8.27 |
| Return on Equity (ROE) | -182.75% | -100.69% | -68.09% | -69.21% | -60.78% | -50.61% |
| Return on Assets (ROA) | -37.53% | -28.77% | -25.13% | -25.92% | -25.43% | -26.10% |
| Return on Capital Employed (ROCE) | -136.80% | -83.10% | -86.40% | -50.30% | -53.30% | -44.60% |
| Earnings Yield | -236.81% | -103.24% | -126.79% | -56.75% | -101.68% | -39.07% |
| FCF Yield | -192.97% | -165.92% | -156.34% | -52.64% | -94.85% | -35.94% |
| Buyback Yield / Dilution | -51.18% | -38.21% | -24.14% | -10.80% | -2.44% | -43.59% |